| First Author | Adam M | Year | 1994 |
| Journal | FEBS Lett | Volume | 338 |
| Issue | 2 | Pages | 170-4 |
| PubMed ID | 8307176 | Mgi Jnum | J:16575 |
| Mgi Id | MGI:64644 | Doi | 10.1016/0014-5793(94)80358-7 |
| Citation | Adam M, et al. (1994) Cloning and expression of three isoforms of the human EP3 prostanoid receptor. FEBS Lett 338(2):170-4 |
| abstractText | Functional cDNA clones coding for three isoforms of the human prostaglandin E receptor EP3 subtype have been isolated from kidney and uterus cDNA libraries. The three isoforms, designated hEP3-I, hEP3-II and hEP3-III, have open reading frames corresponding to 390, 388 and 365 amino acids, respectively. They differ only in the length and amino acid composition of their carboxy-terminal regions, beginning at position 360. The human EP3 receptor has seven predicted transmembrane spanning domains and therefore belongs to the G-protein-coupled receptor family. The rank order of potency for prostaglandins and related analogs in competition for [3H]PGE2 specific binding to membranes prepared from transfected COS cells was comparable for all three isoforms, and as predicted for the EP3 receptor, with PGE2 = PGE1 >> PGF2 alpha = iloprost > PGD2 >> U46619. In addition, the EP3-selective agonist MB28767 was a potent competing ligand with an IC50 value of 0.3 nM, whereas the EP1-selective antagonist AH6909 gave IC50 values of 2-7 microM and the EP2-selective agonist butaprost was inactive. In summary, we have cloned three isoforms of the human EP3 receptor having comparable ligand binding properties. |
